Codify — Article

AB 676 (Gonzalez): Medi‑Cal appeals, timelines, and interest on unrecovered overpayments

Sets formal appeal processes and deadlines, ties interest on unrecovered Medi‑Cal overpayments to the Surplus Money Investment Fund or 7% floor, and creates a narrow waiver pathway for aged audit recoveries.

The Brief

AB 676 instructs the Department of Health Care Services (DHCS) to adopt administrative appeal procedures for audit- and examination-based determinations of Medi‑Cal overpayments, prescribes strict time limits for informal conferences, impartial hearings, and final decisions, and penalizes agency delays by reducing recoverable overpayments. The bill also standardizes how interest is calculated on unrecovered overpayments — using the monthly average earned on the Surplus Money Investment Fund or a 7% simple-interest floor — and creates a discretionary waiver for interest on very old recoveries when specific solvency and fault-based criteria are met.

The measures rework both procedural protections for providers and the financial mechanics of recoupment. Compliance officers, hospital billing departments, DME suppliers, and auditors will need new intake procedures, revised reserve calculations, and to watch how DHCS uses its discretionary waiver and administrative-implementation authority to write the rules that make the statute operational.

At a Glance

What It Does

Requires DHCS to establish administrative appeal processes for audit- and examination-based overpayment findings, sets mandatory timelines for informal conferences, hearings, and final decisions, and prescribes interest on unrecovered overpayments tied to the Surplus Money Investment Fund or 7% simple interest (whichever is higher). It also allows a discretionary interest waiver for certain aged overpayments and gives DHCS authority to issue guidance without formal rulemaking.

Who It Affects

Medi‑Cal providers (hospitals, non‑institutional providers, DME and incontinence-supplies vendors), DHCS appeals staff and auditors, and fiscal compliance teams that manage reserves and repayment agreements. The bill also implicates state cash-management and federal-funding oversight because interest and waivers affect recoveries.

Why It Matters

The bill changes incentives for both the department and providers: it pressures DHCS to decide appeals faster by attaching a financial penalty for delay, alters the economics of repayment through a higher, market‑linked interest standard, and introduces a narrow pathway that can relieve providers of interest on very old audits — potentially preserving fragile safety‑net providers while reducing recoveries to the state.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

AB 676 creates a regulated administrative-appeal framework for disputes that arise from audits and examinations under existing Medi‑Cal audit authorities. DHCS must write regulations establishing appeal channels (including specific references for hospitals), but it may design different tracks for tentative versus final settlements and make tentative-settlement appeals informal.

The statute guarantees providers the right to put grievances in writing and to request hearings, while allowing the agency to resolve matters at an informal level when appropriate.

The bill imposes mandatory, calendared steps: an informal conference no later than 90 days after the provider files a timely, specific statement of disputed issues; an informal-level review completed within 180 days; an impartial hearing no later than 300 days; and fixed windows for final decisions measured from closure of the hearing record — shorter for noninstitutional providers and longer for institutional providers. If DHCS misses the hearing or decision deadlines in specified subdivisions, the ultimately determined overpayment is reduced by 10% for each 30-day period (or portion thereof) of delay, subject to extensions where the provider causes or jointly requests them.On the financial side, the bill sets interest rules for unrecovered overpayments and for recoveries that are later reversed.

Interest on unrecovered amounts begins 60 days after the first demand and accrues at the higher of (a) the monthly average return on the Surplus Money Investment Fund (SMIF) for the month the demand was issued, or (b) a 7% per annum simple-interest floor. If DHCS has already recovered a disallowed payment and the provider later prevails on appeal, the provider is entitled to the higher of the SMIF monthly average or 7% simple interest starting from the later of the department’s formal acceptance of the appeal or the date payment was received.

The statute creates a discretionary waiver for interest when the audit period’s latest date of service was four or more years before the demand, but that waiver is tightly circumscribed by several criteria (community safety‑net importance, fiscal impact, ability to repay, cause of the overpayment, and federal funding considerations).AB 676 also treats durable medical equipment and incontinence-supplies providers differently: interest for those vendors begins the day after the audited period ends and is calculated under a historical tax-code rate referenced in the bill. Finally, DHCS can implement certain provisions via all-county letters or provider bulletins without going through formal rulemaking, and the department’s use of discretionary waiver authority is insulated from routine judicial review except by writ of mandate alleging abuse of discretion.

The Five Things You Need to Know

1

If DHCS fails to hold required hearings or issue final decisions within the statute’s deadlines, any overpayment ultimately determined due is reduced by 10% for each 30‑day period (or portion) of delay, unless the provider caused the delay or requested an extension.

2

Timelines: informal conference within 90 days of a timely dispute filing; informal review completed within 180 days; impartial hearing by 300 days; final decision due within 180 days after record closure for noninstitutional providers and 300 days for institutional providers (with director modification windows extending to 240/420 days in some cases).

3

Interest on unrecovered overpayments begins 60 days after the first demand and accrues at the higher of the monthly Surplus Money Investment Fund return for the month of demand or simple 7% per annum.

4

DHCS must consider, and may waive, interest for unrecovered overpayments where the latest date of service was four or more years before demand — but only if several factors are met (safety‑net importance, fiscal solvency impact, repayment ability, whether the error was departmental or policy‑driven, and federal funding implications) and the waiver is wholly discretionary.

5

DME and incontinence-supplies providers are subject to a different accrual rule: interest starts the day after the audited period ends and is assessed at a rate tied to former Revenue and Taxation Code Section 19269 in effect when accrual begins.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Subdivision (a)

Regulatory requirement to establish appeal processes

DHCS must promulgate regulations creating administrative appeal processes for grievances from audits and examinations (including final settlements). The agency is required to align those regulations with existing Health and Safety Code authority. For compliance teams this means the statutes now mandate a formal rulemaking pathway for appeals architecture and that hospitals’ regulatory references (Title 22 sections) be incorporated into the appeal scheme.

Subdivisions (b)–(c)

Different tracks and informal handling of tentative settlements

The director may establish separate appeal tracks for tentative versus final settlements, but the statute preserves the long-standing practice that tentative cost‑report settlements have no administrative appeal. For tentative settlements that are subject to review, the process is explicitly informal: providers must be allowed to submit grievances in writing, and hearings are discretionary and informal, which lowers procedural burden but also limits formal discovery and evidentiary protections.

Subdivision (d)

Delay penalty: 10% reduction per 30 days missed

The bill makes the timelines in the hearing and decision subsections mandatory and creates a financial sanction on the department for noncompliance: each 30‑day period (or portion) of delay beyond the statutory windows reduces the recoverable overpayment by 10%. The provision preserves extensions where delays are caused by providers or jointly requested, so the penalty primarily targets agency-side slippage and creates a measurable cost of administrative inertia.

6 more sections
Subdivision (e) and (f)

Calendared due‑process windows and director modification procedure

This section lays out concrete deadlines: 90 days to convene an informal conference; 180 days to complete an informal review; 300 days to hold an impartial hearing after dispute filing; and distinct final-decision clocks for noninstitutional (180 days post‑record closure) and institutional providers (300 days). If the director intends to modify a proposed decision, notice and a written‑argument window are required, with extended deadlines: 180/300 days for notice and 240/420 days for the director to issue a final decision unless additional time is granted at the sole request of the provider or jointly.

Subdivision (g)

Interest to providers who prevail after department recovery

If the department has already recouped a disallowed payment but the provider later succeeds on appeal, the provider is entitled to interest equal to the monthly SMIF average or 7% simple interest, whichever is higher. Interest runs from the later of the department’s formal acceptance of the appeal or the date the department received payment, ensuring providers recover some time‑value where they were improperly debited.

Subdivision (h)

Interest on unrecovered overpayments and discretionary waiver criteria

Interest on unrecovered overpayments starts 60 days after DHCS issues the first statement of account status or demand and uses the higher of the SMIF monthly average or 7% simple interest. The department 'may shall' waive interest in repayment agreements for overpayments where the latest date of service was four-plus years before demand, but only after evaluating specific factors: the provider’s role in the local safety net, fiscal solvency impact, repayment capacity, whether the overpayment arose from departmental error or policy change, and whether waiving interest would endanger federal funding. The language vests broad discretion in DHCS while listing criteria the department must consider.

Subdivision (h)(3)–(4)

Enforcement, default remedies, and administrative implementation

If a provider defaults under a repayment agreement, DHCS may use contractual and legal remedies, including offsets against future Medi‑Cal payments, and can reinstate interest. The section also authorizes DHCS to implement parts of the subdivision by all‑county letters, provider bulletins, or similar notices without formal rulemaking, effectively allowing the department to operationalize the statute through guidance documents rather than full regulatory procedures.

Subdivision (i)

Special accrual rule for DME and incontinence supplies

Providers of durable medical equipment and incontinence supplies face a different accrual trigger: interest begins the day after the audited period ends and is calculated using a rate from a former Revenue and Taxation Code provision referenced in the bill. For claims recouped for lack of medical necessity, accrual starts on the date of written demand — a distinction that affects cash-flow planning for specialized vendors.

Subdivision (j)

Judicial review limited to writ alleging abuse of discretion

The director’s final decision remains reviewable under Code of Civil Procedure Section 1094.5 within six months, but the department’s discretionary determinations about exercising waiver authority are insulated from ordinary judicial review; providers can challenge those discretionary acts only via a writ of mandate arguing abuse of discretion. That raises the bar for overturning DHCS judgment on waivers.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Healthcare across all five countries.

Explore Healthcare in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Providers who prevail on appeal: they recover overpayments plus interest calculated at a market‑linked rate, improving prospects for cash restoration when DHCS previously recouped funds.
  • Safety‑net and community hospitals (potentially): the discretionary waiver creates a path to avoid interest on very old overpayments, which can preserve solvency for providers serving vulnerable populations.
  • Compliance teams and counsel at both providers and DHCS: the statute’s fixed timelines and detailed procedures reduce uncertainty about procedural clocks, allowing better planning and resource allocation.

Who Bears the Cost

  • DHCS (administratively and fiscally): the 10% delay penalty and strict calendared obligations increase pressure on staffing and may reduce total recoveries when the department misses deadlines.
  • Providers required to repay recent overpayments: interest begins relatively early (60 days after demand) at a higher, market‑linked rate, increasing the cost of repayment unless a waiver applies.
  • DME and incontinence‑supplies vendors: they face an earlier accrual trigger and a different interest standard, which can accelerate liabilities and complicate billing reserves and cash‑flow management.

Key Issues

The Core Tension

The bill tries to protect providers from stale, unfair recoupments while preserving the state’s ability to reclaim improper Medi‑Cal payments; the central dilemma is that stronger procedural protections and waiver authority reduce financial recoveries and increase administrative complexity, yet aggressive recovery and strict timelines risk harming provider solvency and patient access—there is no frictionless solution that fully secures both fiscal integrity and provider stability.

AB 676 balances speed, provider protections, and recoveries, but several implementation and fairness issues remain unresolved. The 10% per‑30‑day reduction creates a blunt financial penalty designed to force DHCS to meet deadlines, but it risks incentivizing rushed hearings or greater reliance on informal resolutions where factual development is incomplete; rushed resolutions could increase erroneous recoveries or under‑determine complex liability.

The waiver pathway for aged overpayments lists multiple criteria but vests final discretion in DHCS and simultaneously shields those discretionary decisions from routine judicial review, raising concerns about inconsistent application and potential equal‑protection perceptions among providers.

Operationally, allowing DHCS to implement core provisions by all‑county letters and provider bulletins streamlines administration but effectively lets the department shape substantive rules without going through the Administrative Procedure Act’s full notice‑and‑comment process. That shortcut speeds implementation but increases litigation risk and stakeholder uncertainty about the standards DHCS will apply.

The choice to tie interest to a market‑linked SMIF monthly average with a 7% floor hedges against very low market returns, but it also creates volatility in providers’ liabilities and in state‑cash forecasts; the differential treatment of DME vendors adds further complexity because two separate accrual regimes now exist within the Medi‑Cal system.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.